Ralf Ludwig: Bridging Population Data and Immunology in Inflammatory Diseases
Ralf Ludwig, Director of the Lübeck Institute of Experimental Dermatology at the University of Lübeck, shared a post on LinkedIn:
”New Research Topic at Frontiers in Immunology – and we want your best RWD and immunology work.
‘Real-world advances in inflammatory diseases: from population data to immunological mechanisms and clinical impact’
The premise: Population-scale data is most powerful when paired with mechanistic insight.
We’re looking for studies that do both – whether that’s comparative effectiveness of biologics, immune biomarkers at scale, comorbidity mapping, or methods work on causal inference in observational cohorts.
TriNetX, UK Biobank, NHIRD, Clalit, national registries – all welcome.
Editors: Shuo-Yan Gau (Charité), Ralf Ludwig (Lübeck), Uazman Alam (Liverpool), Philip Curman (Karolinska).
Deadline for submission – 4 December 2026.”
Stay updated with Hemostasis Today.
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention